Dr. Willard Guy Andrews III, MD
- Medicare services, 2024
- 396
- Medicare patients, 2024
- 390
- Part D claims, 2024
- 191
- Clinical trials
- 10
- Industry payments
- $106
- Practice address
- 111 S 11th St, Philadelphia, PA 19107
- Practice phone
- Call (215) 955-7106
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Find Dr. Andrews' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Willard Guy Andrews III is a hematologist and oncologist in Philadelphia, Pennsylvania
Dr. Andrews practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.
Dr. Andrews' NPI, 1508890104, was assigned on July 10, 2006. Dr. Andrews graduated from Johns Hopkins University School of Medicine in 1980. Dr. Andrews holds Pennsylvania license MD033516E.
- NPI
- 1508890104NPI Registry (opens in a new tab)
- NPI enumeration date
- July 10, 2006
- NPI status
- Active
- Practice phone
- (215) 955-7106
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 72
- Medical school graduation
- 1980
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Willard Guy Andrews III practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania
Dr. Andrews' primary practice is Thomas Jefferson University Hospital, at 111 S 11th St, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-7106.
- Thomas Jefferson University Hospital111 S 11th St, Philadelphia, PA 19107 · Philadelphia CountyPhone(215) 955-7106
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Willard Guy Andrews III is affiliated with 1 site of care and 2 medical groups
Dr. Andrews' primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. The medical group on file is Abington Pulmonary & Critical Care Associates. Dmand AI also links Dr. Andrews to 1 more medical group, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Willard Guy Andrews III's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andrews practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Thomas Jefferson University Hospital | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Willard Guy Andrews III is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Andrews' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Andrews is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Andrews
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Willard Guy Andrews III billed Medicare for 396 services in 2024
CMS data shows 396 Medicare services from Dr. Andrews across 4 procedure codes in 2024, for 390 Medicare patients. Medicare paid $38,695 for them.
Dr. Andrews' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4962024: 39620%
Where Dr. Andrews' Medicare services took place, 2024
- In an office5414%
- In a facility34286%
Dr. Andrews compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Andrews
- Pennsylvania median
- Medicare services
- 396vs 65439% below
- Medicare patients
- 390vs 22772% above
- Part D claims
- 131vs 39367% below
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Andrews' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Andrews?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Andrews and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Willard Guy Andrews III treated 390 Medicare patients in 2024, average age 76
CMS counts 390 Medicare patients who saw Dr. Andrews in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Andrews' median patient age at 74, with 65% women.
Dr. Andrews' Medicare patients by age, 2024
Dr. Andrews' Medicare patients by sex, 2024
- Women19851%
- Men19249%
Chronic conditions among Dr. Andrews' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis54%
- Chronic kidney disease47%
- Ischemic heart disease43%
- Cancer42%
- Heart failure38%
- Anxiety37%
Share of Medicare patients with each condition. A patient can have several.
Dr. Andrews' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women65%
- Men30%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Willard Guy Andrews III wrote 191 Medicare Part D claims in 2024
In 2024, Dr. Andrews wrote 191 Medicare Part D claims for 40 patients. 64% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $744,304 in total drug cost. In 2023, CMS named 208 claims across 8 drugs.
Dr. Andrews' Part D claims by kind of drug, 2024
- Generic123 claims64%
- Brand-name68 claims36%
Dr. Andrews' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2082024: 13137%
Drugs named by CMS: 6 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Willard Guy Andrews III has worked on 10 clinical trials
Dmand AI links Dr. Andrews to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Carcinoma, Non-Small-Cell Lung and Melanoma. National Cancer Institute (NCI) sponsors the most, 10.
Clinical trials with Dr. Andrews by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Andrews' trials
- Breast Carcinoma In Situ
- Carcinoma, Non-Small-Cell Lung
- Melanoma
- Carcinoma, Bronchogenic
- Nevi and Melanomas
Investigators on the most trials with Dr. Andrews
- James H. Feusner, MD7 shared trials
- George Kovach, MD7 shared trials
- Mehmet Sitki Copur, MD6 shared trials
Recent clinical trials with Dr. Andrews
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma (opens in a new tab)
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair (opens in a new tab)
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Willard Guy Andrews III received $106 in industry payments from 2017 to 2023
CMS Open Payments shows 5 general payments to Dr. Andrews from 5 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 89% of the total. Novartis Pharmaceuticals Corporation paid the most, $33.
General payments to Dr. Andrews by program year, 2017 to 2023
General payments to Dr. Andrews by kind, 2017 to 2023
- Food and beverage$9489%
- Education$1211%
Companies that paid Dr. Andrews the most, 2017 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Willard Guy Andrews III graduated from Johns Hopkins University School of Medicine
Dr. Andrews graduated from Johns Hopkins University School of Medicine in 1980.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Willard Guy Andrews III's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Willard Guy Andrews III
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Willard Guy Andrews III's NPI number?
Dr. Willard Guy Andrews III's NPI number is 1508890104. It was assigned on July 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Willard Guy Andrews III?
Dr. Willard Guy Andrews III is a hematologist and oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Willard Guy Andrews III practice?
Dr. Andrews practices at 111 S 11th St, Philadelphia, PA 19107. Dr. Andrews' primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Dmand AI also links Dr. Andrews to 1 medical group.
What is Dr. Willard Guy Andrews III's office phone number?
The practice phone on file for Dr. Andrews is (215) 955-7106.
What is Dr. Willard Guy Andrews III's medical license number?
Dr. Andrews holds Pennsylvania license MD033516E.
What medical group is Dr. Willard Guy Andrews III part of?
Dr. Andrews is linked to Abington Pulmonary & Critical Care Associates. Dmand AI links Dr. Andrews to 1 more medical group.
Does Dr. Willard Guy Andrews III accept Medicare?
Yes. CMS data shows Dr. Andrews billed Medicare for 396 services in 2024.
How many Medicare patients does Dr. Willard Guy Andrews III see?
CMS counts 390 Medicare patients who saw Dr. Andrews in 2024, with an average age of 76.
What services does Dr. Willard Guy Andrews III bill to Medicare?
In 2024, Dr. Andrews' most billed Medicare services were hospital inpatient care (99222), hospital inpatient care (99223) and office visit, established patient (99214).
Where did Dr. Willard Guy Andrews III go to medical school?
Dr. Andrews graduated from Johns Hopkins University School of Medicine in 1980.
Show 4 more questionsShow fewer questions
What drugs does Dr. Willard Guy Andrews III prescribe most?
In 2024 Medicare Part D data, Dr. Andrews' most prescribed drugs by claims were Anastrozole, Ibrance and Xtandi.
Has Dr. Willard Guy Andrews III received payments from drug or device companies?
CMS Open Payments shows $106 in general payments to Dr. Andrews from 5 companies from 2017 to 2023. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Willard Guy Andrews III been practicing?
Dr. Andrews graduated from medical school in 1980, 46 years ago.
Does Dr. Willard Guy Andrews III do research?
Dr. Andrews has worked on 10 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card